Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline before and after peritrochanteric fracture surgery for postoperative independent walking
IRCT20230926059523N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of sertraline in anxiety disorder and obsessive compulsive disorder (OCD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Independent walking based on the TUG test, Hamilton anxiety score change and 1 more. Started May 2025; status: completed.
02
Drugs
sertraline
03
Conditions
anxiety disorderobsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20230926059523N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230926059523N2.